Skip to main content
. Author manuscript; available in PMC: 2019 Apr 26.
Published in final edited form as: Biomacromolecules. 2018 Dec 18;20(1):469–477. doi: 10.1021/acs.biomac.8b01365

Figure 4.

Figure 4.

Biodistribution profiles of PepMV and PVX 24 h post intravenous administration at a dose of 10 mg kg−1 in nu/nu mice bearing MDA-MB-231 triple negative breast cancer tumors. (A) Ex vivo fluorescence images of excised organs. (B) Quantitative region of interest (ROI) analysis of each organ determined by total radiant efficiency per area. Data are expressed as means ± SD (n = 3).